20525 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
METHODS OF TREATING CANCER
#2BICYCLIC FERROPORTIN INHIBITORS
#3COMPOSITIONS AND METHODS FOR TREATING DEMENTIA
#4COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#5METHOD OF ENHANCING THE BIOAVAILABILITY OF BIOACTIVE CHEMICAL COMPOUNDS AND THERAPEUTIC DRUGS, NOVEL BIOAVAILABLE COMPOUNDS, AND METHODS OF USE
#6TYLOSIN DERIVATIVE AND PREPARATION METHOD AND APPLICATION THEREOF
#7RUTHENIUM COMPLEXES FOR INHIBITION OF GALECTINS, METHOD OF THEIR PREPARATION, AND USE THEREOF
#8COMPOUNDS, DEVICES, AND USES THEREOF
#9VIRAL INHIBITORS, THE SYNTHESIS THEROF, AND INTERMEDIATES THERETO
#10PRODRUG ATHELIAPYRROLIDINE COMPOUND AND METHODS OF USE
#11VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#12EXTENDED RELEASE FORMULATIONS COMPRISING SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF
#13COMPOSITIONS AND APPLICATIONS THEREOF
#14HEART VALVE PROSTHESES WITH A DRUG ELUTING MECHANISM
#15VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#16VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#17GLYCOSYLATED COMPOSITIONS AND METHODS OF USE
#18COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#19PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#20COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#21MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#22USE OF MARIBAVIR IN TREATMENT REGIMENS
#23MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#24PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#25CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
#26IDENTIFICATION OF A NEW POTENT INHIBITOR OF MYCOBACTERIAL GROWTH
#27PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ACNE
#28TOPICAL COMPOSITIONS
#29INHIBITING PURINE BIOSYNTHESIS TO INCREASE FAVIPIRAVIR POTENCY AGAINST RNA VIRUS INFECTIONS
#30VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#31ALTERNATIVELY SPLICED ISOFORM IN CANCER AND METHODS OF USE THEREOF
#32SYNTHESIS OF GLYCOSYLATED HYDROXYTRYPTAMINE COMPOUNDS AND METHODS OF THEIR USE
#33COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#34HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#35CAP ANALOG FOR THE 5'-END OF EUKARYOTIC MESSENGER RNAS
#36PSEUDO-DISACCHARIDE COMPOUNDS
#37COMPOSITIONS FOR PROMOTING LONGEVITY AND METHODS OF USING THE SAME
#38LINCOSAMIDES AND USES THEREOF
#39CHAGA MUSHROOM-RELATED FORMULATIONS, CHEMICAL COMPOUNDS, AND METHODS OF PRODUCTION AND USE THEREOF
#40TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#41TOPICAL COMPOSITIONS
#42WOUND HEALING DEVICE AND METHODS FOR WOUND HEALING
#43REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS
#44MANNOSE-TARGETED COMPOSITIONS
#45METHODS AND COMPOSITIONS FOR LOCALIZED PRODUCTION AND DELIVERY OF BIOLOGICAL MOLECULES
#46METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE
#47INHIBITOR OF CELLULAR PURINE NUCLEOTIDE SALVAGE PATHWAY ENZYME FOR USE IN THE TREATMENT AND/OR PREVENTION OF HELICOBACTER PYLORI INFECTION AND/OR DISEASE ASSOCIATED WITH SUCH INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#48POLYMER-COATED NANOPARTICLES AND PREPARATION METHOD THEREFOR
#49HEATING APPARATUS AND METHODS
#50METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)
#51CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-(1 BETA-L-RIBOFURANOSYL)1H-BENZIMIDAZOLE
#52USE OF MARIBAVIR IN TREATMENT REGIMENS
#53COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#54ACETYLATED SIALIC ACID GLYCOCLUSTERS AND THEIR USES FOR TREATING INFECTIOUS DISEASES
#55USE OF MARIBAVIR IN TREATMENT REGIMENS
#56PHOTODYNAMIC THERAPY AND DIAGNOSIS
#57ALS TREATMENT USING INDUCED REGULATORY T (ITREG) CELLS
#58INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES
#59GLYCOMIMETIC BINDERS FOR L-SIGN
#60Fitusiran for Use in Improving Patient-Reported Outcome in Hemophilia Patients
#61Methods for Treating HCV
#62W/O/W MICROEMULSIONS FOR OCULAR ADMINISTRATION
#63GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR
#64COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#65MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#66USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES
#67MARIBAVIR COMPOSITIONS AND USES THEREOF
#68Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan
#69NEW COMBINATION DRUG FOR TREATING CORONAVIRUS INFECTIONS, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#70Viral inhibitors, the synthesis thereof, and intermediates thereto
#71VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#72Viral inhibitors, the synthesis thereof, and intermediates thereto
#73COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#74COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER
#75USE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA (PGC1ALPHA) AGONISTS TO IMPROVE EX VIVO EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS)
#76MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#77METHODS OF INDUCING ORGAN TRANSPLANTATION IMMUNE TOLERANCE AND ASSOCIATED COMPOSITIONS AND METHODS
#78Pharmaceutical Compositions And Methods For Treating Neoplasia
#79Topical compositions
#80MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#81NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#82USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS
#83Topical Composition and Carrier for Administration of Pharmaceutically or Cosmetically Active Ingredients
#84SUCCINIC ACID AND DERIVATIVES FOR THE TREATMENT OF HAEMOTOLOGICAL DISORDERS
#85THERAPEUTIC USE OF COMBINATION INCLUDING TRIPLE AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS
#86NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#87Use of maribavir in treatment regimens
#88COMPOUNDS, DEVICES, AND USES THEREOF
#89VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#90PROTEOLYSIS TARGETING COMPOUND WITH TISSUE TARGETING CAPABILITY AND USE THEREOF
#91Topical compositions
#92COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES
#93THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME
#94TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS USING ANTI-BAFFR ANTIBODIES
#95METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS
#96METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS
#97Antiviral compositions comprising liposome-encapsulated ascorbyl glucoside and natural extracts
#98PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF INFECTIONS AND ANTIBACTERIAL-INDUCED DYSFUNCTIONS
#99SYSTEMS AND METHODS FOR TREATMENT OF BACTERIAL VAGINOSIS
#100NOVEL COMPOUND OR SALT THEREOF, AND ANTITUMOR ACTIVATOR CONTAINING SAME AS ACTIVE INGREDIENT
#101USE OF MARIBAVIR IN TREATMENT REGIMENS
#102Branched Linkers for Antibody-Drug Conjugates and Methods of Use Thereof
#103INHIBITORS OF SGLT-1 AND USES THEREOF
#104SKIN SOLUTION WITH SOLUBILIZED BAKUCHIOL
#105HBV INHIBITOR AND ITS USE
#106TREATMENT OF HEPATITIS E VIRUS INFECTION WITH INTERFERON LAMBDA
#107COMPOSITION FOR PRODUCING A BONE REPLACEMENT MATERIAL, METHOD FOR PRODUCING A PHARMACEUTICAL EXCIPIENT, PHARMACEUTICAL EXCIPIENT, AND USE THEREOF
#108METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19
#109NOVEL USES
#110AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF
#111Methods and Compositions for Treating Leucine Rich Repeat Kinase 2 (LRRK2)-Associated Disorder or Condition
#112DRUGS, THERAPEUTIC COMBINATIONS AND METHODS FOR PREVENTING VIRAL AND MICROBIAL INFECTIONS AND THEIR SEQUELAE
#113USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
#114W/O/W MICROEMULSIONS FOR OCULAR ADMINISTRATION
#115CELLULAR-ANTIMICROBIAL COMBINATION COMPOSITION AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS OF JOINTS AND SOFT TISSUES
#116COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND NICOTINAMIDE RIBOSIDE FOR CELLULAR ENERGY
#117METHODS FOR ENHANCING CYTOTOXIC CANCER THERAPY THROUGH MODULATION OF PURINE BIOSYNTHESIS PATHWAYS
#118Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
#119TERPENOID DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION
#120Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#121BETALAIN COMPOSITIONS AND METHODS THEREFOR
#122MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING
#123AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS
#124COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#125Spirolactone compounds
#126USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS
#127NOVEL USES
#1282-DEOXY-D-GLUCOSE FOR PREVENTION AND TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF COVID-19
#129HAPLOIDENTICAL MIXED CHIMERISM FOR TREATING AUTOIMMUNE DISEASES
#130Nucleoside Analogues to Inhibit the Main Protease of a Coronavirus
#131INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES
#132CROSS-LINKED MEDICATION FOR TREATMENT OF CORONAVIRAL INFECTION AND METHOD OF TREATMENT
#133Cysteine protease inhibitors and methods of use thereof
#134ECLITASERTIB FOR USE IN TREATING CONDITIONS INVOLVING SYSTEMIC HYPERINFLAMMATORY RESPONSE
#135ELIMINATION OF COLONIC BACTERIAL DRIVING LETHAL INFLAMMATORY CARDIOMYOPATHY
#136Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
#137Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#138METHODS FOR ANALYSIS OF SOMATIC MOBILE ELEMENTS, AND USES THEREOF
#139METHODS FOR IMMUNOTHERAPY
#140ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF
#141ANTIBACTERIAL PRODUCTS
#142METHODS AND SYNERGIC COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#143TETRACYCLIC COMPOUND
#144TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS
#145METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS INFECTION
#146COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND THE USE THEREOF
#147METHODS TO PREVENT, AMELIORATE AND TREAT COMPLICATIONS FROM VIRAL INFECTIONS
#148SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF
#149COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS
#150CXCR4 INHIBITOR FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND VIRAL INFECTIONS
#151IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY INTO IMMUNE CELLS
#152Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom
#153COMPOSITIONS AND APPLICATIONS THEREOF
#154METHODS OF TREATING TUMORS
#155USE OF ADEFOVIR DIPIVOXIL AND STRUCTURAL ANALOG THEREOF FOR TREATING PSEUDORABIES VIRUS
#156Method of treatment of topical dermatologic acne using a cream composition and method of manufacture
#157TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT
#158COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#159METHODS OF TREATING CANCER
#160METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS
#161Methods and compositions for treatment of COVID-19
#162COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSION
#163Compositions containing Verteporfin, Ribavirin, Gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#164Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps
#165Novel Immunodulating Small Molecules
#166USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES
#167USE OF SGLT2 INHIBITORS TO TREAT PRIMARY BILLIARY CHOLANGITIS
#168USE OF COMPOUND IN PREVENTING OR TREATING GRAFT VERSUS HOST DISEASE
#169AN AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF
#170Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole
#171Topical compositions
#172METHODS FOR THE PREPARATION OF RIBOSIDES
#173Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#174Methods And Compositions For Treating Viral Diseases Using Combination Of Drugs
#175Combination pharmaceutical agents as RSV inhibitors
#176Methods for Increasing the Bioavailability of OTC and Pharmaceutical Drugs
#177Methods and Compositions for Treating Cancer
#178INHIBITING APE2 EXPRESSION IN A SUBJECT TREATED WITH A DRUG AGENT THAT CAUSES INCREASED APE2 EXPRESSION
#179TETRACYCLIC COMPOUND
#180MEDICAMENT AND FOOD FOR PREVENTING OR TREATING NOVEL CORONAVIRUS PNEUMONIA COVID-19 AND USE THEREOF
#181Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
#182Galactoside inhibitor of galectins
#183Methods for Treating HCV
#184DRUG TREATMENT AND BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION
#185TOPICAL JAK INHIBITOR COMBINATION COMPOSITIONS FOR TREATMENT OF INFLAMMATORY SKIN CONDITIONS
#186HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
#187POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY
#188NOVEL ANTIVIRAL THERAPIES
#189SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
#190COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#191USE OF E-SELECTIN ANTAGONISTS TO ENHANCE THE SURVIVAL OF RECONSTITUTED, BONE MARROW-DEPLETED HOSTS
#192COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS
#193ONCE-DAILY TREATMENT OF PULMONARY FIBROSIS
#194COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE
#195COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#196COMBINATION THERAPIES FOR CANCER TREATMENT
#197METHODS OF TREATMENT FOR BACTERIAL INFECTIONS
#198COMBINATION THERAPIES INCLUDING INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE
#199USES OF A2 DOMAIN OF VON WILLEBRAND FACTOR
#200COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
#201MEDICINAL VAGINAL LACTOBACILLUS COCKTAIL
#202HBV inhibitor and its use
#203METHODS AND COMPOSITIONS FOR TREATING EUKARYOTIC INFECTIONS VIA ALTERING AGGREGATION DYNAMICS OF RAPTOR/KOG1
#204SYSTEMIC ISOXAZOLINE PARASITICIDES FOR VECTOR-BORNE AND VIRAL DISEASE TREATMENT OR PROPHYLAXIS
#205METHOD FOR TREATING INFECTIOUS DISEASES BY TARGETING NK CELL IMMUNE CHECKPOINT
#206COMPOSITIONS AND THERAPEUTIC METHODS
#207Mannose derivatives for treating bacterial infections
#208Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
#209AMP-activated protein kinase activating compounds and uses thereof
#210COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#211COMPOSITIONS AND METHODS FOR INHIBITING INOSINE MONOPHOSPHATE DEHYDROGENASE
#212COMPOSITIONS AND METHODS FOR INHIBITING INOSINE MONOPHOSPHATE DEHYDROGENASE
#213APPLICATION OF 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES IN ANTIVIRAL THERAPY
#214COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#215USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
#216Galectin-3 inhibiting c-glycosides
#217Combination formulation of two antiviral compounds
#218Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy
#219COMPOUNDS FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#220Heating apparatus and methods
#221Immune Supplement Composition
#222TREATMENT OF INFECTIONS OF TOXOPLASMA GONDII AND CLOSELY RELATED PARASITES
#223Conditioning regimens and methods for inducing mixed chimerism
#224Enhanced in Vivo Targeting of Site-Specific Drugs
#225PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF 1`-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS
#226COMPOSITIONS FOR HERPESVIRUS TRANSCRIPTIONAL FEEDBACK CIRCUIT DISRUPTION AND USES THEREOF
#227Method and composition for inhibiting growth of bacterium
#228USE OF SGLT2 INHIBITORS TO TREAT PRIMARY SCLEROSING CHOLANGITIS
#229Methods for treating and virus infections
#230NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY
#231Therapeutic agents and methods of producing same
#232NEW USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST
#233PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#234Sustained release injectable formulation containing a poly L lactic acid filler and a hyaluronic acid filler conjugate and a method for preparing the same
#2354'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
#236Pre-Activated Nucleoside IMPDH Inhibitors As Anti-Infective Drugs
#237ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK
#238NOVEL HYDROGEL CONJUGATES
#239Crystalline form of compound and uses thereof in medicine
#240WOUND PREVENTION AND/OR TREATMENT AND RELATED COMPOUNDS, MATRICES, COMPOSITIONS, METHODS AND SYSTEMS
#241METHOD FOR TREATING PRIMARY SCLEROSING CHOLANGITIS
#242Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
#243PHARMACEUTICAL COMPOSITIONS OF RIBAVIRIN
#244METHOD OF TREATING AND PREVENTING CORONAVIRUSES WITH LOW DOSAGE INTERFERON BETA-1A AS A TH17 INHIBITOR
#245METHODS OF TREATING VIRAL INFECTIONS USING INHIBITORS OF NUCLEOTIDE SYNTHESIS PATHWAYS
#246Compositions for oral cancer or an oropharyngeal cancer
#247Use of angiotensin II type 2 receptor agonist
#248ASCORBIC ACID, QUINONE COMPOUND, AND SODIUM GLUCOSE COTRANSPORTER INHIBITOR FOR TREATING CANCER
#249Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health
#250ALS treatment using induced regulatory T (iTREG) cells
#251METHODS FOR TREATING CANCER WITH MANUFACTURED T CELLS
#252SUCCINIC ACID AND DERIVATIVES FOR THE TREATMENT OF HAEMOTOLOGICAL DISORDERS
#253Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
#254Betalain compositions and methods therefor
#255Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#256PH-responsive polymer-drug conjugates for enhanced antibacterial efficacy
#257Fused tricyclic compounds and uses thereof in medicine
#258AMP-activated protein kinase activating compounds and uses thereof
#259Compositions and methods of treating acne and photoaging
#260Compositions Containing Verteporfin, Ribavirin, Gemcitabine, or Combinations Thereof and Methods of Use for Treating COVID-19, Cancer, or Non Cancer Diseases
#261IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#262Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating COVID-19, cancer, or non cancer diseases
#263Targeting PAX2 for the treatment of breast cancer
#264Compression Bandaging
#265Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine Asignaling and/or adenosine Areceptor expression
#266Mebendazole prodrugs with enhanced solubility and oral bioavailability
#267Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
#268Methods for treating degenerative disc disease and chronic lower back pain
#269AZA-PYRIDONE COMPOUNDS AND USES THEREOF
#270Compounds and methods for treating bacterial infections
#271Pharmaceutical compositions for prevention and/or treatment of infections and antibacterial-induced dysfunctions
#272RETINOID TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS
#273Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
#274Use of SGLT-2 inhibitors in the drying-off of non-human mammals
#2755-LIPOXYGENASE ANTAGONISTS
#276ROS-RESPONSIVE MICRONEEDLE PATCH FOR ACNE VULGARIS TREATMENT
#277Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways
#278Methods and Compositions for Hair Growth by Activating Autophagy
#279Spirolactone compounds
#280Compositions and Methods for Treating Dry Eye Diseases
#281Benzalkonium-embedded mesostructured silica compositions and uses of same
#282COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#283Skin-like condoms having active ingredients to enhance a male erection and a female arousal
#284METHODS OF TREATING HAIR RELATED CONDITIONS
#285Method for treating post-prandial hypoglycemia
#286TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#287RIBAVIRIN PERFLUBRON EMULSION COMPOSITION FOR TREATING VIRAL DISEASES
#288ANTIVIRAL COMPOUNDS
#289Methods for treating virus infections
#290Skin-like condoms having active ingredients to enhance a male erection and a female arousal
#291Topical compositions
#292MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#293Compositions and methods for treating an infection
#294CONJUGATE OF CYTOTOXIC DRUG AND PRODRUG FORM OF SAID CONJUGATE
#295Combination formulation of two antiviral compounds
#296Methods and synergic compositions for treating viral infections
#297Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates
#298Pharmaceutical compositions comprising silica microspheres
#299METHODS FOR THE TREATMENT OF ROSACEA
#300Targeted intracellular delivery of antiviral agents